EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial Intelligence-Driven Strategies for Targeted Delivery and Enhanced Stability of RNA-Based Lipid Nanoparticle Cancer Vaccines

Ripesh Bhujel iD, Viktoria Enkmann, Hannes Burgstaller, Ravi Maharjan iD

Pharmaceutics · 30.07.2025 · 17 (8) · 992

DOI: 10.3390/pharmaceutics17080992 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 30.07.2025. Verfasst von Ripesh Bhujel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dhulikhel Hospital, Dhulikhel 45210, Nepal. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The convergence of artificial intelligence (AI) and nanomedicine has transformed cancer vaccine development, particularly in optimizing RNA-loaded lipid nanoparticles (LNPs). Stability and targeted delivery are major obstacles to the clinical translation of promising RNA-LNP vaccines for cancer immunotherapy. This systematic review analyzes the AI’s impact on LNP engineering through machine learning-driven predictive models, generative adversarial networks (GANs) for novel lipid design, and neural network-enhanced biodistribution prediction. AI reduces the therapeutic development timeline through accelerated virtual screening of millions of lipid combinations, compared to conventional high-throughput screening. Furthermore, AI-optimized LNPs demonstrate improved tumor targeting. GAN-generated lipids show structural novelty while maintaining higher encapsulation efficiency; graph neural networks predict RNA-LNP binding affinity with high accuracy vs. experimental data; digital twins reduce lyophilization optimization from years to months; and federated learning models enable multi-institutional data sharing. We propose a framework to address key technical challenges: training data quality (min. 15,000 lipid structures), model interpretability (SHAP > 0.65), and regulatory compliance (21CFR Part 11). AI integration reduces manufacturing costs and makes personalized cancer vaccine affordable. Future directions need to prioritize quantum machine learning for stability prediction and edge computing for real-time formulation modifications.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligence (AI)high-throughput screeningimmunotherapylipid nanoparticles (LNPs)machine learningoptimizationpersonalized RNA-LNP cancer vaccinesstabilitytargeted delivery

Autor:innen und Institutionen

  • Dhulikhel Hospital, Dhulikhel 45210, Nepal.
  • RNAAnalytics Advanced Research GmbH, Frauentorgasse 72-74, 3430 Tulln, Austria.
  • Global Reference Laboratories Pvt. Ltd., Kathmandu 44600, Nepal.
  • Yonsei University, Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea.

ORCID-Profile: Ripesh Bhujel, Ravi Maharjan

Zitieren

APA

Bhujel, R., Enkmann, V., Burgstaller, H., & Maharjan, R. (2025). Artificial Intelligence-Driven Strategies for Targeted Delivery and Enhanced Stability of RNA-Based Lipid Nanoparticle Cancer Vaccines. Pharmaceutics, 17(8), 992. https://doi.org/10.3390/pharmaceutics17080992

Vancouver

Bhujel R, Enkmann V, Burgstaller H, Maharjan R. Artificial Intelligence-Driven Strategies for Targeted Delivery and Enhanced Stability of RNA-Based Lipid Nanoparticle Cancer Vaccines. Pharmaceutics. 2025;17(8):992. doi:10.3390/pharmaceutics17080992

BibTeX
@article{Bhujel2025,
  author = {Bhujel, Ripesh and Enkmann, Viktoria and Burgstaller, Hannes and Maharjan, Ravi},
  title = {Artificial Intelligence-Driven Strategies for Targeted Delivery and Enhanced Stability of RNA-Based Lipid Nanoparticle Cancer Vaccines},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {8},
  pages = {992},
  doi = {10.3390/pharmaceutics17080992}
}
Kostenlos starten →